Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PAO Group Inc PAOG

Healthcare Medical Care
PAO Group Inc is the United States-based holding company. It seeks to develop, acquire, partner, or participate in, companies and concepts in the development and launch of alternative medicine clinics focused on non-traditional patient care solutions. The range of treatment solutions includes cannabis, acupuncture, chiropractic, biofeedback, and other solutions depending on patient needs. The... see more

Recent & Breaking News (OTCPK:PAOG)

PAOG Expects To Finalize CRO Engagement For Cannabis Drug Within Next Two Weeks

PR Newswire October 15, 2020

PAOG Releases Cannabis Drug Development Update

Newsfile October 15, 2020

PAOG Targets Spring Launch of Hemp Cultivar Facility

Newsfile October 13, 2020

PAOG Advances Independent Research of Cannabis Drug RespRx

PR Newswire October 7, 2020

PAOG Announces CEO Interview Discussing Cannabis Investigational New Drug Application Plans With FDA

PR Newswire October 2, 2020

PAOG CEO Jim DiPrima Answers Questions About Cannabis Investigational New Drug Application Plans with FDA

Newsfile October 2, 2020

This Week on MoneyTV with Donald Baillargeon, 10/2

Accesswire October 2, 2020

PAOG Announces New Engagement To Prepare For Investigational New Drug Application With FDA

PR Newswire October 1, 2020

PAOG Engages Saul Kaye, Founder of iCAN: Israel-Cannabis and CannaTech to Prepare RespRx for IND

Newsfile October 1, 2020

PAOG Cannabis Pharmaceutical Research Initiative Gains New Traction

Newsfile September 30, 2020

PAOG Sees Broader Cannabis Pharma Treatment Opportunity

PR Newswire September 24, 2020

PAOG Expands Cannabis Pharma Treatment Research

Newsfile September 24, 2020

This Week on MoneyTV with Donald Baillargeon, 9/18

Accesswire September 18, 2020

PAOG CBD Pharma Development Initiative In Puerto Rico Could Get Boost From COVID-19

PR Newswire September 17, 2020

PAOG Target, CBD Pharma Development, In Puerto Rico Could Get Boost From COVID-19

Newsfile September 17, 2020

PAOG To Build Pharmaceutical Hemp Cultivar Facility On PURA Farmersville Site

PR Newswire September 16, 2020

PAOG Announces Agreement to Build Pharmaceutical Hemp Cultivar Facility on PURA Farmersville Site

Newsfile September 16, 2020

PAOG Advances RespRx Research Into International CBD Pharma Research Arena

Newsfile September 15, 2020

PAOG Takes CBD Pharmaceutical Research Global To Target $5.8 Billion Market

PR Newswire September 15, 2020

PAOG Goes Global with CBD Pharmaceutical Research to Target $5.8 Billion Market

Newsfile September 15, 2020